[Differential regulation of the release of norepinephrine and neuropeptide Y]
- PMID: 1482247
[Differential regulation of the release of norepinephrine and neuropeptide Y]
Abstract
The release of catecholamines and their co-neurotransmitter neuropeptide Y was investigated in conscious dogs with neurogenic arterial hypertension elicited by sinoaortic denervation. One month after denervation, an elevation of catecholamine levels (measured by HPLC) without elevation of neuropeptide Y levels in plasma (evaluated by RIA) has been found. This dissociation could be explained by a transient release of neuropeptide Y during the first weeks after surgery; a depletion of neuronal neuropeptide Y due to the permanent sympathetic stimulation; or an insufficient increase in sympathetic tone. To test these three hypotheses, we investigated the time courses of catecholamine and neuropeptide Y levels in arterial plasma during the first five weeks after sinoaortic denervation; and the responses to yohimbine (an alpha 2 antagonist which enhances transmitter release). Resting neuropeptide Y levels in plasma remained normal during the first five weeks after sinoaortic denervation. In normal dogs, a high dose of yohimbine (0.5 mg/kg i.v.) elevated both catecholamine (6-fold) and neuropeptide Y levels (1.5-fold), whereas a lower dose (0.05 mg/kg i.v.) induced a two fold elevation of catecholamine levels without changing neuropeptide Y concentrations. In sinoaortically denervated dogs, yohimbine elicited elevation of both catecholamines and neuropeptide Y whatever the dose used. Thus, neurogenic arterial hypertension in dogs seams to involve catecholamines but not neuropeptide Y. Moreover, the present work suggests that a high level of sympathetic stimulation is required for a co-release of catecholamines and neuropeptide Y.
Similar articles
-
Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation?Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):431-6. doi: 10.1007/BF00176621. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1620243
-
[Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].Arch Mal Coeur Vaiss. 1991 Aug;84(8):1239-41. Arch Mal Coeur Vaiss. 1991. PMID: 1659347 French.
-
Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.Br J Pharmacol. 1992 Jan;105(1):181-3. doi: 10.1111/j.1476-5381.1992.tb14232.x. Br J Pharmacol. 1992. PMID: 1596679 Free PMC article.
-
Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.J Cardiovasc Pharmacol. 1987;10 Suppl 12:S51-68. J Cardiovasc Pharmacol. 1987. PMID: 2455193 Review.
-
Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.Herz. 1995 Jun;20(3):169-86. Herz. 1995. PMID: 7635399 Review.
Cited by
-
Levels of plasma neuropeptide Y and other vasoactive substances during head-up tilt in normal and essential hypertensive subjects.Clin Auton Res. 1995 Apr;5(2):67-70. doi: 10.1007/BF01827465. Clin Auton Res. 1995. PMID: 7620295 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical